FIELD: medicine.
SUBSTANCE: invention relates to the field of biotechnology, namely to recombinant vaccines against Candida albicans, and can be used in medicine. A vaccine for the treatment or prevention of the Candida infection contains an isolated polypeptide with SEQ ID NO: 2 in an effective quantity, which can be fused with a fusion partner. The vaccine can also contain an adjuvant.
EFFECT: invention makes it possible to increase the effectiveness of treatment or prevention of the Candida infection.
11 cl, 6 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
| APPLICATION YEAST STRAIN Komagataella pastoris AS RECIPIENT FOR CONSTRUCTION OF PRODUCERS OF TARGET PROTEIN | 2013 |
|
RU2522479C1 |
| ACETOIN PRODUCTION METHOD | 2015 |
|
RU2686614C2 |
| METHOD OF DIAGNOSING INVASIVE CANDIDIASIS AND SPECIES IDENTIFICATION OF ITS MAIN PATHOGENS USING PCR WITH HYBRIDIZATION-FLUORESCENT DETECTION IN REAL TIME | 2022 |
|
RU2809386C1 |
| METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 |
|
RU2814730C1 |
| TREATMENT OF MYCOTIC INFECTION WITH ANTIMYCOTIC PREPARATIONS OUT OF POLYENIC GROUP OR THAT OF BETA-GLUCANSINTASE INHIBITORS IN COMBINATION WITH ANTI-hsp90-ANTIBODIES | 2001 |
|
RU2262952C2 |
| Lactobacillus fermentum Ess-1, DSM17851, AND ITS APPLICATION FOR TREATMENT AND/OR PREVENTION OF CANDIDOSIS AND URINARY TRACT INFECTIONS | 2006 |
|
RU2413761C1 |
| STRAIN OF BACTERIA Enterococcus faecium WITH ABILITY TO REDUCE FORMATION OF BIOFILMS BY Candida fungus | 2015 |
|
RU2576008C2 |
| CURTAILED SECRETABLE ASPARTYL-PROTEINASE 2 | 2008 |
|
RU2493255C2 |
